Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001536029 | SCV001752722 | likely pathogenic | Fanconi anemia complementation group D2 | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001536029 | SCV005057632 | likely pathogenic | Fanconi anemia complementation group D2 | 2024-02-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005001226 | SCV005626517 | uncertain significance | not provided | 2024-07-10 | criteria provided, single submitter | clinical testing | Identified in an individual with a history of breast and/or ovarian cancer, but additional clinical information was not included (PMID: 27153395); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27153395) |